[Antibacterial activity of ristocetin, kanamycin and farmiglucine in association with other antibiotics]. 1964

G Donati, and L Pierangeli, and A Vellucci, and G Tallarida

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin

Related Publications

G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
March 1959, La Clinica terapeutica,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
November 1958, La Riforma medica,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
March 1958, Antibiotics & chemotherapy (Northfield, Ill.),
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
January 1963, Giornale italiano di chemioterapia,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
January 1977, Giornale italiano di chemioterapia,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
November 1962, El Dia medico,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
June 1984, Antimicrobial agents and chemotherapy,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
September 1967, Annals of internal medicine,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
January 1958, Antibiotics annual,
G Donati, and L Pierangeli, and A Vellucci, and G Tallarida
January 1985, Drugs,
Copied contents to your clipboard!